Table 3.
Clinical course in both groups
| Clinical course | Hydroxychloroquine (n = 97) | Control (n = 97) | P-value |
|---|---|---|---|
| Disease severity after 28 days, n (%) | |||
| Recovered | 52 (53.6) | 33 (34.0) | 0.06 |
| Mild | 23 (23.7) | 39 (40.2) | |
| Moderate | 8 (8.2) | 11 (11.3) | |
| Severe | 8 (8.2) | 9 (9.2) | |
| Death | 6 (6.1) | 5 (5.1) | |
| Need for ICU | 11 (11.3) | 13 (13.4) | 0.83 |
| Duration to negative PCR, mean ± SD | 17.01 ± 2.98 | 17.64 ± 2.45 | 0.11 |
| Duration to clinical improvement, mean ± SD | 9.43 ± 1.87 | 9.52 ± 2.94 | 0.80 |
| Duration to hospital discharge, mean ± SD | 11.04 ± 2.71 | 11.27 ± 2.19 | 0.52 |